MX2020007368A - Composiciones estables de corticosteroides. - Google Patents
Composiciones estables de corticosteroides.Info
- Publication number
- MX2020007368A MX2020007368A MX2020007368A MX2020007368A MX2020007368A MX 2020007368 A MX2020007368 A MX 2020007368A MX 2020007368 A MX2020007368 A MX 2020007368A MX 2020007368 A MX2020007368 A MX 2020007368A MX 2020007368 A MX2020007368 A MX 2020007368A
- Authority
- MX
- Mexico
- Prior art keywords
- corticosteroid compositions
- stable corticosteroid
- corticosteroid
- antioxidant
- stable
- Prior art date
Links
- 239000003246 corticosteroid Substances 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 239000003963 antioxidant agent Substances 0.000 abstract 2
- 230000003078 antioxidant effect Effects 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La invención se refiere a composiciones farmacéuticas que comprenden un corticosteroide y un antioxidante. La invención se refiere además a métodos para tratar, prevenir o aliviar los síntomas de inflamación asociada con enfermedades inflamatorias y condiciones del tracto gastrointestinal que comprenden administrar las composiciones farmacéuticas que comprenden un corticosteroide y un antioxidante.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862616213P | 2018-01-11 | 2018-01-11 | |
| PCT/US2019/012965 WO2019140032A1 (en) | 2018-01-11 | 2019-01-10 | Stable corticosteroid compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020007368A true MX2020007368A (es) | 2020-10-12 |
Family
ID=67139230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020007368A MX2020007368A (es) | 2018-01-11 | 2019-01-10 | Composiciones estables de corticosteroides. |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11260064B2 (es) |
| EP (1) | EP3737380A4 (es) |
| JP (1) | JP7482777B2 (es) |
| KR (1) | KR20200108023A (es) |
| CN (1) | CN111741756A (es) |
| AU (1) | AU2019207717B2 (es) |
| BR (1) | BR112020013996A2 (es) |
| CA (1) | CA3086022A1 (es) |
| EA (1) | EA202091679A1 (es) |
| IL (1) | IL275394B1 (es) |
| MX (1) | MX2020007368A (es) |
| WO (1) | WO2019140032A1 (es) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4830853A (en) | 1986-10-20 | 1989-05-16 | Warner-Lambert Company | Drug compositions stabilized against oxidation |
| JP2704983B2 (ja) * | 1995-01-18 | 1998-01-26 | ミナト製薬株式会社 | 浴槽用脱塩素剤 |
| US5837252A (en) * | 1996-07-01 | 1998-11-17 | Larreacorp, Ltd. | Nontoxic extract of Larrea tridentata and method of making same |
| US6495534B2 (en) * | 2000-05-15 | 2002-12-17 | Pharmacia & Upjohn Spa | Stabilized aqueous suspensions for parenteral use |
| GB0224909D0 (en) | 2002-10-25 | 2002-12-04 | Norgine Europe Bv | Colon cleansing compositions |
| CA2608631C (en) | 2005-06-09 | 2014-07-29 | Biolipox Ab | Method and composition for treating inflammatory disorders |
| CN101939024A (zh) * | 2007-11-13 | 2011-01-05 | 梅里蒂奇制药公司 | 用于治疗胃肠炎的组合物 |
| WO2009137672A1 (en) * | 2008-05-07 | 2009-11-12 | Salix Pharmaceuticals, Ltd. | Methods of treating bowel disease by administering a bowel cleanser and an antibiotic |
| NZ740722A (en) * | 2013-03-29 | 2019-04-26 | Ocean Farma Srl | Oral suspension for treating eosinophilic esophagitis |
-
2019
- 2019-01-10 US US16/244,219 patent/US11260064B2/en active Active
- 2019-01-10 MX MX2020007368A patent/MX2020007368A/es unknown
- 2019-01-10 AU AU2019207717A patent/AU2019207717B2/en active Active
- 2019-01-10 EA EA202091679A patent/EA202091679A1/ru unknown
- 2019-01-10 KR KR1020207022799A patent/KR20200108023A/ko not_active Application Discontinuation
- 2019-01-10 WO PCT/US2019/012965 patent/WO2019140032A1/en unknown
- 2019-01-10 IL IL275394A patent/IL275394B1/en unknown
- 2019-01-10 CA CA3086022A patent/CA3086022A1/en active Pending
- 2019-01-10 CN CN201980008120.7A patent/CN111741756A/zh active Pending
- 2019-01-10 JP JP2020536545A patent/JP7482777B2/ja active Active
- 2019-01-10 EP EP19738625.3A patent/EP3737380A4/en not_active Withdrawn
- 2019-01-10 BR BR112020013996-3A patent/BR112020013996A2/pt active Search and Examination
-
2021
- 2021-09-20 US US17/479,485 patent/US11564934B2/en active Active
-
2022
- 2022-12-23 US US18/146,156 patent/US20230140144A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112020013996A2 (pt) | 2020-12-01 |
| US20190209587A1 (en) | 2019-07-11 |
| EP3737380A1 (en) | 2020-11-18 |
| US20230140144A1 (en) | 2023-05-04 |
| US11564934B2 (en) | 2023-01-31 |
| IL275394B1 (en) | 2024-07-01 |
| IL275394A (en) | 2020-07-30 |
| US11260064B2 (en) | 2022-03-01 |
| AU2019207717A1 (en) | 2020-07-02 |
| JP2021510370A (ja) | 2021-04-22 |
| EP3737380A4 (en) | 2021-09-29 |
| CA3086022A1 (en) | 2019-07-18 |
| EA202091679A1 (ru) | 2020-10-12 |
| WO2019140032A1 (en) | 2019-07-18 |
| KR20200108023A (ko) | 2020-09-16 |
| US20220000885A1 (en) | 2022-01-06 |
| JP7482777B2 (ja) | 2024-05-14 |
| AU2019207717B2 (en) | 2024-08-01 |
| CN111741756A (zh) | 2020-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123126T1 (el) | Συνθεσεις για την αγωγη γαστρεντερικης φλεγμονης | |
| CY1123845T1 (el) | Τοπικα φαρμακευτικα σκευασματα για την αγωγη φλεγμονωδων καταστασεων | |
| MX2017011037A (es) | Bacteria manejada geneticamente para tratar enfermedades que se benefician de inflamacion intestinal reducida y/o barrera mucosa intestinal fortalecida. | |
| MX2019015311A (es) | Composiciones de ésteres de ácido cannabidiólico y usos de las mismas. | |
| NZ720478A (en) | Autotaxin inhibitor compounds | |
| WO2017136792A8 (en) | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier | |
| EP3684373A4 (en) | COMPOSITIONS AND METHODS FOR TREATING AND IMPROVING RESPIRATORY CONDITIONS AND MUCOUS INFLAMMATION | |
| MX2022001796A (es) | Metodos y composiciones para inhibir los sintomas asociados con la veisalgia. | |
| WO2015099838A3 (en) | Compositions and methods of treating ocular diseases | |
| MX2018001756A (es) | Benzimidazoles sustituidos, su preparacion y su uso como productos farmaceuticos. | |
| EA201991387A1 (ru) | ТРИЦИКЛИЧЕСКИЕ ЕНОНЫ - ПРОИЗВОДНЫЕ ПИРИМИДИНА ДЛЯ ИНГИБИРОВАНИЯ ROR-γ И ДРУГИХ ПРИМЕНЕНИЙ | |
| MY174797A (en) | Anti-inflammatory compositions | |
| NZ739867A (en) | Aminonaphthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases | |
| MX2022008479A (es) | Combinaciones de brimonidina de dosis baja y usos de las mismas. | |
| CY1123279T1 (el) | Κορτικοστεροειλη για τη θεραπεια φλεγμονωδων παθησεων της γαστρεντερικης οδου | |
| MX2015010490A (es) | Composicion farmaceutica para el tratamiento de helicobacter pylori. | |
| MX2019009586A (es) | Composiciones y metodos para tratar enfermedades asociadas con la permeabilidad del epitelio intestinal. | |
| EP4356962A3 (en) | Selective il-6-trans-signalling inhibitor compositions | |
| MX2010002559A (es) | Composiciones y metodos para tratar enfermedades y desordenes inmulogicos e inflamatorios. | |
| WO2019043176A3 (en) | HISTONE-DEACETYLASE INHIBITOR IN COMBINATION WITH ANTIMETABOLITE AGENT FOR CANCER THERAPY | |
| MX2021003643A (es) | Derivados de terpenoides y usos de los mismos. | |
| WO2019004788A3 (ko) | 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물 | |
| WO2019036725A3 (en) | PEPTIDE INHIBITORS OF TAU AGGREGATION | |
| GB2537783A (en) | Methods and compositions used in treating inflammatory and autoimmune diseases | |
| MX2020007368A (es) | Composiciones estables de corticosteroides. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights |
Owner name: VIROPHARMA BIOLOGICS LLC |